Company Filing History:
Years Active: 2003-2011
Title: Ann Marie Janson: Innovator in Neurological Treatments
Introduction
Ann Marie Janson is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of neuroscience, particularly in the treatment of central nervous system disorders. With a total of 4 patents to her name, her work is paving the way for innovative therapies.
Latest Patents
One of her latest patents focuses on the treatment of Parkinson's disease using PDGF. This invention outlines methods to influence central nervous system cells to produce progeny that are beneficial in treating CNS disorders. Specifically, it includes techniques for exposing patients to reagents that modulate the proliferation, migration, differentiation, and survival of these cells, ultimately aiming to reduce symptoms associated with the disorder.
Another notable patent involves ependymal neural stem cells and methods for their isolation. This invention describes a specific type of ependymal neural CNS stem cell that expresses the surface protein Notch 1, along with other proteins. It also details the pharmaceutical preparations that include these stem cells, as well as various in vitro and in vivo assays based on their unique properties.
Career Highlights
Ann Marie Janson is currently associated with Neuronova AB, where she continues her research and development in neurological therapies. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in the treatment of CNS disorders.
Collaborations
Throughout her career, Ann has collaborated with notable colleagues, including Ming Zhao and Kioumars Delfani. These partnerships have enhanced her research efforts and expanded the impact of her inventions.
Conclusion
Ann Marie Janson's work exemplifies the intersection of innovation and healthcare. Her patents not only reflect her expertise but also hold the potential to transform the treatment landscape for neurological disorders.